Athos Capital’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,417
| Closed | -$295K | – | 50 |
|
|
2024
Q1 | $295K | Hold |
25,417
| – | – | 0.32% | 26 |
|
|
2023
Q4 | $179K | Hold |
25,417
| – | – | 0.2% | 27 |
|
|
2023
Q3 | $143K | Buy |
+25,417
| New | +$143K | 0.07% | 43 |
|
|
2023
Q2 | – | Sell |
-29,768
| Closed | -$302K | – | 71 |
|
|
2023
Q1 | $302K | Hold |
29,768
| – | – | 0.21% | 63 |
|
|
2022
Q4 | $299K | Hold |
29,768
| – | – | 0.17% | 86 |
|
|
2022
Q3 | $293K | Hold |
29,768
| – | – | 0.12% | 107 |
|
|
2022
Q2 | $292K | Hold |
29,768
| – | – | 0.11% | 121 |
|
|
2022
Q1 | $291K | Hold |
29,768
| – | – | 0.1% | 112 |
|
|
2021
Q4 | $289K | Hold |
29,768
| – | – | 0.09% | 115 |
|
|
2021
Q3 | $290K | Hold |
29,768
| – | – | 0.07% | 130 |
|
|
2021
Q2 | $287K | Buy |
+29,768
| New | +$287K | 0.06% | 150 |
|